Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis

BACKGROUND: Biologicals are the cornerstone for many treatment algorithms in inflammatory arthritis. While tumour necrosis factor (TNF) inhibitors may achieve important responses in ∼50% of patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA), a significant fraction of patients are pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Carron, Philippe, Lambert, Bieke, Van Praet, Liesbet, De Vos, Filip, Varkas, Gaëlle, Jans, Lennart, Elewaut, Dirk, Van den Bosch, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932275/
https://www.ncbi.nlm.nih.gov/pubmed/27403334
http://dx.doi.org/10.1136/rmdopen-2016-000265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932275/
https://www.ncbi.nlm.nih.gov/pubmed/27403334
http://dx.doi.org/10.1136/rmdopen-2016-000265

Ejemplares similares